Barak Ben Arye - 31 Dec 2025 Form 5 Insider Report for NovoCure Ltd (NVCR)

Role: General Counsel
Signature: Steven Robbins, as attorney in fact for Ben Arye, Barak
Issuer symbol: NVCR
Transactions as of: 31 Dec 2025
Net transactions value: +$1,187
Form type: 5
Filing time: 08 Jan 2026, 16:21:25 UTC
Previous filing: 01 Jul 2025
Next filing: 03 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Ben Arye Barak	General Counsel	C/O NOVOCURE INC., 1550 LIBERTY RIDGE DRIVE, SUITE 115, WAYNE	Steven Robbins, as attorney in fact for Ben Arye, Barak	08 Jan 2026	0001917165

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVCR	Ordinary Shares	Award	$1,187	+108	+0.06%	$10.99	174,573	31 Dec 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person is reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of July 1, 2025 through December 31, 2025. This transaction is also exempt under Rule 16b-3(c).
F2	In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on December 31, 2025.